3 - Agents used for Hyperkeratosis Flashcards
The following are agents used for the treatment of hyperkeratosis:
(1) salicylic acid (BHA or a phenolic aromatic acid)
(2) sulfur
(3) tar
(4) urea
(5) lactic acid (AHA)
(6) glycolic acid (AHA)
True
Salicylic acid and salicylates (which are easily converted to salicylic acid) are present in willow bark, wintergreen leaves and sweet birch
True
Salicylic acid has been classified as either a beta-hydroxy acid (BHA) or more accurately as a phenolic aromatic acid
True (unlike a true BHA, salicylic acid has both the hydroxyl and carboxyl groups directly attached to an aromatic benzene ring and the hydroxyl group exhibits acid properties; whereas the hydroxyl group of a true BHA is neutral)
Salicylic acid is lipid soluble and therefore miscible with epidermal lipids
True (in contrast to AHA such as Glycolic acid and lactic acid which are water soluble)
Salicylic acid is lipid soluble and therefore miscible with sebaceous glands lipids in hair follicles
True (in contrast to AHA such as Glycolic acid and lactic acid which are water soluble)
Salicylic acid is lipid soluble and therefore can interact with lipids that surround keratinised cells
True (in contrast to AHA such as Glycolic acid and lactic acid which are water soluble)
Salicylic acid is lipid soluble and therefore is able to interact with multilamellar structures surrounding keratinocytes in the stratum corneum and in hair follicles
True (in contrast to AHA such as Glycolic acid and lactic acid which are water soluble)
Because of the greater lipophilic qualities of salicylic acid in contrast to the water solubility of AHA, the clinical effect of salicylic acid may be limited to the superficial epidermis
True (AHA free acids may penetrate deeper into the epidermis and dermis as well)
Salicylic acid has a pKa (acid dissociation constant) of 2.98 and must be formulated at a proper pH to allow enough free acid to be present to obtain a significant exfoliative effect
True (various formulations with concentrations of salicylic acid at a pH close to pKa give significantly more exfoliation than formulation at any pH significantly greater than the pKa)
Salicylic acid formulations with concentrations of at a pH close to its pKa (acid dissociation constant) give significantly more exfoliation than formulation at any pH significantly greater than the pKa
True (salicylic acid pKa = 2.98)
Salicylic acid has keratolytic and desmolytic effects
True (desmolytic more accurately describes the mechanism of action)
Salicylic acid and its derivatives have sunscreen effects (such as the UVB absorber octisalate/octyl salicylate)
True (therefore topical Salicylic acid which is frequently used in psoriasis can interfere with UVB phototherapy for psoriasis)
Salicylates such as acetylsalicylate (aspirin) and Salicylic acid have anti-inflammatory properties
True (the anti-inflammatory effect of a Salicylic acid is most pronounced at 0.5% and 5%)
Salicylic acid exerts its keratolytic and desmolytic effects by:
(1) reducing corneocyte adhesion
(2) loosening and causing detachment of corneocytes
True
The term ‘desmolytic’ is more preferable to ‘keratolytic’ in regard to the mechanism of action of salicylic acid as Salicylic acid disrupts the cellular junctions (desmosomes) rather than lysing/breaking intercellular keratin filaments
True (acts as an organic solvent to remove the intercellular lipid linking the cornified cells)
Salicylic acid causes a more irregular and thinner stratum corneum without altering the epidermal thickness
True (in contrast the AHA that thins the stratum corneum, but increases thickness of the viable epidermis and dermis)
Salicylic acid is used for the following hyperkeratotic disorders:
(1) calluses
(2) corns
(3) hyperkeratosis
(4) ichthyosis
(5) keratoderma
True
Calluses/corn = 2-20% Salicylic acid in collodion-based paint and gels, 10-50% Salicylic acid in a plaster
Hyperkeratosis = 6% Salicylic acid multi vesicular emulsion cream
Ichthyosis/keratoderma = 6% Salicylic acid + 60% propylene glycol + 20% ethanol
Salicylic acid is used for the following cosmetic indications:
(1) hyperpigmentation
(2) rejuvenation/peeling
True
Salicylic acid is used for the following papulosquamous dermatosis:
(1) psoriasis
True
Salicylic acid is used for the following cutaneous infections:
(1) dermatophyte infections
(2) verruca (HPV)
True
Dermatophyte = 6% Salicylic acid + 12% benzoic acid in wool fat and petrolatum (Whitfield’s ointment), 10% Salicylic acid + 20% urea for avulsing toenails
Verruca = 2-20% Salicylic acid in collodion-based paint and gels, 10-50% Salicylic acid in a plaster
Salicylic acid is used for the following dermatitis:
(1) cradle cap
(2) seborrhoeic dermatitis
True
Shampoos with 2% Salicylic acid, often in combination with tar and Sulfur
Salicylic acid may be used in acne vulgaris due to its mild comedolytic effects
True
In the treatment of psoriasis, Salicylic acid is added into topical preparations containing dithranol to prevent its oxidation
True
In the treatment of psoriasis, the original Lassar’s paste contained 2% Salicylic acid + 24% zinc oxide + 24% starch + 50% WSP
True (although compounds duplicating the original Lassar’s paste should always be freshly prepared because the ingredients combine to form zinc salicylate on standing) - modern formulations of Lassar’s paste do not contain Salicylic acid because of the interaction of salicylic acid and zinc oxide
In treatment of psoriasis, compounding calcipotriene with Salicylic acid should be avoided as this results in instability of calcipotriene when mixed with Salicylic acid
True
Salicylic acid has been used for pruritus
True (antipruritic formulations at a concentration of 1-2%)
Salicylic acid has been used for painful aphthous ulcers and for topical musculoskeletal symptomatic pain relief
True
Aphthous ulcers = choline salicylate
MSK pain = methyl salicylate found in oil of wintergreen
Salicylic has been used as a superficial peeling agent as part of Jessner’s solution which consists of 14% Salicylic acid + 14% resorcinol + 14% lactic acid in ethanol
True
Salicylic acid in concentrations of 20-30% in a hydroethanolic vehicle is also used as a superficial chemical peel for acne, photodamage, and hyperpigmentation
True
The effect of salicylic acid in chemical peeling procedures is largely related to epidermal injury
True
50% Salicylic acid ointment has been used to treat severely photodamaged hands and forearms
True
1-2% Salicylic acid is used as an exfoliant to increase corneocyte shedding and improve the appearance of aged skin
True
Salicylic acid has been used in hyperhidrosis
True (2% Salicylic acid to 15% aluminium chloride hexahydrate is efficacious and less irritating than preparations that contained aluminium chloride hexahydrate only)
When applied topically to the skin, Salicylic acid is readily absorbed
True (risk of systemic absorption and salicylism)
Percutaneous absorption of salicylic acid is enhanced by incorporation into hydrophilic ointment
True (risk of systemic absorption and salicylism)
If Salicylic acid is applied to erythrodermic skin, it can be detected in the urine within 24 hours
True (risk of systemic absorption and salicylism)
Percutaneous absorption of salicylic acid is enhanced by tape stripping of the stratum corneum
True (risk of systemic absorption and salicylism)
Percutaneous absorption of salicylic acid is enhanced by application under occlusion
True (risk of systemic absorption and salicylism)
Systemic toxicity due to percutaneous absorption of salicylic acid is rare, but a potentially serious event as salicylates in high concentrations are toxic to the CNS
True
Salicylates in high concentrations causes CNS toxicity including nausea, vomiting, tinnitus, confusion, dizziness, delirium, psychosis, stupor, coma and death
True
Tinnitus due to salicylate toxicity is caused by increased labyrinthine pressure and effects on cochlear hair cells secondary to vasoconstriction in the auditory microvasculature
True
Salicylate toxicity stimulates the medullary respiratory centre in the brain that causes marked hyperventilation and respiratory alkalosis, and in infants and children metabolic acidosis may occur
True